Kaushik J. Dave, Executive Vice President at ANTARES PHARMA, INC. (ATRS), sold 12,000 shares at $4.02 ($48K) on 2013-05-06, disclosed to the SEC on 2013-05-08.
Scheduled sale ($48k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |